Skip to main content

People in the News: Jun 18, 2009


Massachusetts Institute of Technology researcher and Alnylam Pharmaceuticals co-founder Phillip Sharp has been named chair of the Cancer Prevention and Research Institute of Texas' scientific review council, which oversees the selection of the agency's research grants.

CPRIT was established in 2007 to issue $3 billion over 10 years to fund grants for cancer research and prevention.

Opko Health has named Jamie Freedman as vice president of research and development and business development.

Freedman was previously CEO of Locus Pharmaceuticals. Before that, he held various positions at Merck Research Labs. He has an MD and PhD from Tufts University.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.